Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 55.98B P/E 16.50 EPS this Y 16.90% Ern Qtrly Grth -4.50%
Income 2.96B Forward P/E 13.65 EPS next Y 11.30% 50D Avg Chg 2.00%
Sales 313.75B PEG 1.12 EPS past 5Y 18.01% 200D Avg Chg 9.00%
Dividend N/A Price/Book N/A EPS next 5Y 13.85% 52W High Chg -4.00%
Recommedations 1.90 Quick Ratio 0.46 Shares Outstanding 129.68M 52W Low Chg 25.00%
Insider Own 0.10% ROA 4.24% Shares Float 129.42M Beta 0.44
Inst Own 88.59% ROE - Shares Shorted/Prior 1.98M/2.06M Price 413.07
Gross Margin 4.05% Profit Margin 0.94% Avg. Volume 851,172 Target Price 604.23
Oper. Margin 1.45% Earnings Date Nov 6 Volume 1,405,784 Change 1.99%
About McKesson Corporation

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

McKesson Corporation News
11/21/24 McKesson Stock Gains 34.1% YTD: What's Driving the Rally?
11/21/24 MCK Stock Down Despite Latest Partnership to Boost SCD Treatment
11/21/24 McKesson Corporation (NYSE:MCK) is favoured by institutional owners who hold 89% of the company
11/14/24 Investors Can Find Comfort In McKesson's (NYSE:MCK) Earnings Quality
11/13/24 McKesson Stock Gets A RS Rating Lift To 75
11/13/24 All You Need to Know About McKesson (MCK) Rating Upgrade to Buy
11/13/24 Baltimore wins $266 million in opioid case against distributors
11/13/24 Are Investors Undervaluing Cardinal Health (CAH) Right Now?
11/13/24 McKesson (MCK) Is Considered a Good Investment by Brokers: Is That True?
11/13/24 Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
11/12/24 McKesson Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
11/11/24 Here is Why Growth Investors Should Buy McKesson (MCK) Now
11/11/24 Here's Why McKesson (MCK) is a Strong Momentum Stock
11/11/24 5 Stocks That Look Promising Following Broker Rating Upgrades
11/08/24 Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
11/07/24 MCK Stock Gains as Q2 Earnings & Sales Top Estimates, '25 EPS View Up
11/07/24 McKesson Corp (MCK) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...
11/06/24 McKesson (MCK) Q2 2025 Earnings Call Transcript
11/06/24 McKesson (MCK) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
11/06/24 McKesson (MCK) Q2 Earnings and Revenues Beat Estimates
MCK Chatroom

User Image SamaraMarkets Posted - 1 day ago

🚨 MYNZ Petra Brand Ambassador says to keep an eye on "BIG NEWS from the NFL." This is going to run parabolic soon, right after the healthcare giant Thermo Fisher ($210B mkt cap) partnered with Mainz to develop and launch together ColoAlert in US 🚀 Buy the dip now, the train is leaving very soon. $MCK $MRVL $ACN

User Image Stonkapedia Posted - 2 days ago

$MCK this stock is a badass b**ch. Y’all can keep your tech and biotech with 50+ PEs. This is where it’s at. IYKYK 🤙

User Image Berk33 Posted - 2 days ago

$MCK

User Image SparkyReturns Posted - 2 days ago

$MCK Hey, anyone looking for an investing idea in the biotech space would do well to check out ICU - SeaStar Medical. Last quarter was the first time they started to book revenue from their SCD device which is unique and has received FDA grants and also multiple Breakthrough Device Designations. They just took over direct sales from a prior distributor, and revenue is ramping up rapidly. Eventually every hospital ICU in the country will have to buy these as it becomes new standard of care for treating sepsis and CKD. They have NO competition. It is at the inflection point and could bounce hard from the current bottom forming. Likely blockbuster at the gate. Cheers! $AMGN $BIIB $SNY

User Image GoSoftlanding Posted - 3 days ago

$MCK need much more time

User Image swingingtech Posted - 4 days ago

$MCK https://wallstreetwaves.com/mckesson-reaches-analyst-target-price/

User Image Edujimenez29 Posted - 4 days ago

$MCK sad reality is i only own one share left 😆

User Image investwithdiamondick Posted - 6 days ago

$MCK is this where I should add?

User Image smartkarma Posted - 1 week ago

$MCK | McKesson Corporation: Will Its Cost Optimization & Operational Efficiencies Help Alter The Playing Field? - Major Drivers "McKesson Corporation's second quarter fiscal 2025 results present a multidimensional view of the company's current financial standing and future..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/mckesson-corporation-will-its-cost-optimization-operational-efficiencies-help-alter-the-playing-field-major-drivers

User Image smartkarma Posted - 1 week ago

$MCK | McKesson Corporation: Will Its Cost Optimization & Operational Efficiencies Help Alter The Playing Field? - Major Drivers "McKesson Corporation's second quarter fiscal 2025 results present a multidimensional view of the company's current financial standing and future..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/mckesson-corporation-will-its-cost-optimization-operational-efficiencies-help-alter-the-playing-field-major-drivers

User Image TradeTherapyLLC Posted - 1 week ago

$LLY $MCK $PFE $XLV Here is the backside to the 'three hills and a mountain' pattern. Right on que...

User Image GoSoftlanding Posted - 1 week ago

$MCK Doesn't seem to be any purchase happening at the moment. In the long term, the 560-630 area needs to be reorganized.

User Image IN0V8 Posted - 1 week ago

$MCK Opportunity Citigroup raises target price to $713 from $630

User Image RenaissanceTrading Posted - 1 week ago

$MCK Target achieved!

User Image LordWellesley Posted - 1 week ago

The Veradigm acquisition will be a game changer for McKesson $MCK $MDRX

User Image Stonkapedia Posted - 1 week ago

$MCK get IT!

User Image GoSoftlanding Posted - 1 week ago

$MCK 700' on the way.

User Image LordWellesley Posted - 1 week ago

This would be a great addition to the $MCK portfolio. Veradigm can unlock a world of real world evidence for pharma development. https://seekingalpha.com/news/4271782-mckesson-oracle-thoma-bravo-among-finalists-to-acquire-veradigm-report

User Image jeffmeredith Posted - 1 week ago

$MCK Great recovery here, I was shaken out at a loss. This went from $637.51 at the start of August to as low as $464.42 in late September. I had a $560 dip buy that didn't pan out, but it's now back to $613. Most of my mistakes are made out of a lack of patience.

User Image contangoz Posted - 2 weeks ago

Aug highs testing $mck

User Image contangoz Posted - 2 weeks ago

$MCK pop on way, model suggests 627 by next thursday

User Image 50bps Posted - 2 weeks ago

$MCK got shaken out like a vodka martini. pathetic

User Image Breastman0726 Posted - 2 weeks ago

@Dollellama44 lol same… only one I hit was $MCK lol

User Image TradeTherapyLLC Posted - 2 weeks ago

$PFE $XLV $LLY $MCK An excerpt from this week's Clarity spotlight on Pfizer: "A rare candlestick pattern, called ‘three hills and a mountain,’ has recently appeared in XLV (Healthcare Select Sector SPDR ETF). This pattern, less common on traders’ radar, involves building long positions across ‘three hills,’ followed by a shift to short, and then resetting long to form the ‘mountain,’ where a retail shakeout often precedes a sharp price rise. With limited data on the pattern’s final phase, it showcases how strategic timing by fund managers can shape a stock’s ‘personality’ within the sector. For example, this is the second time XLV has formed the three hills pattern."

User Image GoSoftlanding Posted - 2 weeks ago

$MCK this chart can test 700' in short time of period.

User Image cubie Posted - 2 weeks ago

$mck congrats giddy bulls🤭😅

User Image cubie Posted - 2 weeks ago

@ribbey @judgeyoung3 @judgeyoung2 @Alvi722 @jenbunn @EBE_Day @Ollip @TraderRapp @tonyctl @lukenight $celh like $hubs, maybe scam.street think there's buyer for bo and $mck had earnings Ah yesterday, 2 dozen+ stonks had earnings cubie didn't even know mck had🙈😅

User Image cubie Posted - 2 weeks ago

@judgeyoung2 @Alvi722 @jenbunn @EBE_Day @Ollip @ribbey @TraderRapp @tonyctl @lukenight @indievestments what's $mck news

User Image Stonkapedia Posted - 2 weeks ago

$AMZN isn’t life grand? Love me some $AMZ $WMT $MCK 💪🏼

User Image rachid1980 Posted - 2 weeks ago

$MCK out @597$ will be good choice 🤢

Analyst Ratings
Deutsche Bank Buy Sep 25, 24
Baird Neutral Sep 24, 24
Wells Fargo Equal-Weight Sep 13, 24
Citigroup Buy Sep 10, 24
Leerink Partners Outperform Sep 5, 24
JP Morgan Overweight Aug 21, 24
Barclays Overweight Aug 8, 24
Evercore ISI Group Outperform Aug 8, 24
Baird Outperform Aug 8, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Smith LeAnn B EVP & Chief HR Offic.. EVP & Chief HR Officer Nov 03 Sell 461.26 660 304,432 1,325 11/06/23
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer Oct 12 Sell 460 10,521 4,839,660 67,408 10/13/23
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer Oct 12 Option 134.21 10,521 1,412,023 70,340 10/13/23
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer Sep 06 Sell 407 3,938 1,602,766 117,900 09/07/23
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer Aug 03 Sell 422.6 3,938 1,664,199 121,838 08/07/23
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer Jun 13 Sell 400 3,471 1,388,400 129,714 06/14/23
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer Jun 13 Option 159 3,471 551,889 133,185 06/14/23
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer Jun 05 Sell 391.25 3,938 1,540,742 130,996 06/07/23
Vitalone Britt J. EVP & CFO EVP & CFO May 31 Sell 373.28 13,330 4,975,822 14,028 06/01/23
Rodgers Thomas L EVP, Chief Strategy.. EVP, Chief Strategy & BDO May 31 Sell 373.28 6,044 2,256,104 2,544 06/01/23
Schechter Lori A. EVP, Chief Legal Off.. EVP, Chief Legal Officer & GC May 31 Sell 373.28 11,195 4,178,870 186 06/01/23
Avila Nancy EVP, CIO & CTO EVP, CIO & CTO May 31 Sell 373.28 5,759 2,149,720 4,631 06/01/23
Avila Nancy EVP, CIO & CTO EVP, CIO & CTO May 26 Sell 389.14 1,821 708,624 10,390 05/31/23
Avila Nancy EVP, CIO & CTO EVP, CIO & CTO May 26 Option 0 1,207 12,686 05/31/23
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer May 10 Sell 386.04 18,542 7,157,954 75,737 05/11/23
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer May 10 Option 182.77 18,542 3,388,921 94,279 05/11/23
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer Feb 02 Sell 380 7,416 2,818,080 75,737 02/06/23
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer Feb 02 Option 182.77 7,416 1,355,422 83,153 02/06/23
Schechter Lori A. EVP, Chief Legal Off.. EVP, Chief Legal Officer & GC Dec 09 Sell 379.79 2,500 949,475 4,178 12/12/22
Rodgers Thomas L EVP, Chief Strategy.. EVP, Chief Strategy & BDO Sep 08 Sell 367.21 1,300 477,373 2,544 09/09/22
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer Jun 21 Sell 305.20 1,535 468,482 75,737 06/22/22
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer Jun 16 Sell 305.39 4,767 1,455,794 77,272 06/17/22
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer Jun 13 Sell 308.31 3,232 996,458 82,039 06/14/22
Flores Nancy EVP, CIO & CTO EVP, CIO & CTO May 27 Sell 332.38 2,061 685,035 4,726 06/01/22
Schechter Lori A. EVP, Chief Legal Off.. EVP, Chief Legal Officer & GC May 27 Sell 332.38 6,838 2,272,814 120 06/01/22
Schechter Lori A. EVP, Chief Legal Off.. EVP, Chief Legal Officer & GC May 27 Option 144.43 5,488 792,632 5,608 06/01/22
Faber Tracy EVP & Chief HR Offic.. EVP & Chief HR Officer May 27 Sell 332.38 7,979 2,652,060 06/01/22
Vitalone Britt J. EVP & CFO EVP & CFO May 27 Sell 333.57 27,281 9,100,123 13,693 05/31/22
Rodgers Thomas L EVP, Chief Strategy.. EVP, Chief Strategy & BDO May 25 Option 0 884 4,237 05/27/22
Rodgers Thomas L EVP, Chief Strategy.. EVP, Chief Strategy & BDO May 25 Sell 330.27 527 174,052 3,362 05/27/22
Schechter Lori A. EVP, Chief Legal Off.. EVP, Chief Legal Officer & GC May 25 Option 0 21,205 26,617 05/27/22
Schechter Lori A. EVP, Chief Legal Off.. EVP, Chief Legal Officer & GC May 25 Sell 330.27 24,169 7,982,296 1,470 05/27/22
Faber Tracy EVP & Chief HR Offic.. EVP & Chief HR Officer May 25 Option 0 5,852 10,780 05/27/22
Faber Tracy EVP & Chief HR Offic.. EVP & Chief HR Officer May 25 Sell 330.27 2,185 721,640 7,979 05/27/22
Rodgers Thomas L EVP, Chief Strategy.. EVP, Chief Strategy & BDO May 24 Sell 326.9 209 68,322 3,353 05/25/22
Vitalone Britt J. EVP & CFO EVP & CFO May 24 Sell 325.14 4,192 1,362,987 27,395 05/25/22
Faber Tracy EVP & Chief HR Offic.. EVP & Chief HR Officer May 24 Sell 326.9 1,433 468,448 6,617 05/25/22
Schechter Lori A. EVP, Chief Legal Off.. EVP, Chief Legal Officer & GC May 24 Sell 326.9 1,500 490,350 12,841 05/25/22
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer May 17 Option 159 8,678 1,379,802 8,678 05/18/22
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer May 17 Sell 331.43 8,678 2,876,150 05/18/22
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer May 13 Option 237.86 5,438 1,293,483 5,438 05/16/22
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer May 13 Sell 322.97 5,438 1,756,311 05/16/22
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer May 09 Option 237.86 5,438 1,293,483 5,438 05/11/22
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer May 09 Sell 330.93 5,438 1,799,597 05/11/22
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer Apr 29 Option 237.86 5,438 1,293,483 5,438 05/02/22
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer Apr 29 Sell 319.36 5,438 1,736,680 05/02/22
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer Apr 18 Option 237.86 5,438 1,293,483 5,438 04/20/22
TYLER BRIAN S. Chief Executive Offi.. Chief Executive Officer Apr 18 Sell 323.25 5,438 1,757,834 04/20/22
Flores Nancy EVP, CIO & CTO EVP, CIO & CTO Apr 07 Sell 311.09 3,298 1,025,975 5,440 04/08/22
Vitalone Britt J. EVP & CFO EVP & CFO Mar 10 Option 144.43 6,324 913,375 18,256 03/14/22